Integration of the Hamilton Microlab Star within HtL at AstraZeneca R&D Charnwood
News Jun 06, 2007
AstraZeneca requires automation of multiple applications across different processes. The use of the flexible and modular Microlab® Star enables AstraZeneca to use one instrument for diverse applications ranging from compound dilution to assay construction.
Working closely with AstraZeneca, Hamilton have designed a system that has greater capacity and functionality than AstraZeneca’s previous machines, enabling them to carry out accurate dilutions.
The Microlab STAR’s features like “Dual Liquid Level Detection”, “Monitored Air Dipslacement” and the CO-RE technology have increased the process safety remarkably at AstraZeneca.
The Hamilton Software has been incorporated into the in-house sample management system, which has enabled full sample/data tracking and an increase in the speed of sample processing.
The Microlab STAR system shows a decrease in assay variability and an increase in throughput and accuracy. As a result the Microlab STAR has become the benchmark instrument within HtL at AstraZeneca R&D Charnwood.
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences ProductsNews
BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.READ MORE
Sciformix Corporation Collaborates with Oracle Health SciencesNews
New collaboration enables faster and more informed drug safety decisions.READ MORE